跳至主要内容
临床试验/NCT02951663
NCT02951663已完成不适用

Evaluation of Body Composition and Metabolism Following Bariatric Surgery, Effects of a Protein Supplement: A Feasibility Study

University of North Carolina, Chapel Hill1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2016年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
48
试验地点
1
主要终点
Number of patients reporting gastrointestinal effects during use of supplementation

研究概览

简要总结

Purpose: To evaluate adherence, tolerability, and total protein intake in bariatric surgery patients provided with ready-to-drink protein supplements, and to evaluate the effects of supplementation on body composition, metabolism, and health outcomes.

Participants: Patients scheduled to under go bariatric surgery aged 18-70 years old. Participants will be included if they agree to comply with the study protocol, are free of medical conditions that may contraindicate participation, and do not plan to become pregnant during the study.

Procedures (methods): Participants will complete five laboratory visits for the current study (pre-screening (visit 1), baseline testing (visit 2), and return visits at 3 weeks (visit 3), 12 weeks (visit 4), and 24 weeks (visit 5) post-surgery). The treatment group will be given a 12 week supply of a high protein, low-carbohydrate, low-fat supplement to be taken once daily during days 3-7 post-surgery, and twice daily weeks 2-12. The treatment group will follow standard of care recommendations put forth by the physician-nutritionist team, but using the provided protein supplement to meet recommendations. The control group will be asked to follow the standard of care recommendations from the physician-nutritionist team.

The primary study endpoints will be adherence, tolerability, and total protein intake in bariatric surgery patients provided with a 12-week supply of ready-to-drink protein supplements. Secondary outcomes will evaluate the effect of a protein supplement on body composition (lean mass, fat mass, percent body fat, visceral fat, muscle thickness), resting metabolic rate, clinical and endocrine blood values, functional fitness, and responses to questionnaires evaluating mood, satiety, functional independence, and health related quality of life.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Care Provider)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Participant is scheduled for weight loss surgery
  • •Participant agrees to abstain from extraneous supplementation with creatine, β-hydroxy β-methylbutyrate, carnosine, beta-alanine, taurine, or any other supplement or prescription drug that may significantly influence body composition or metabolic rate
  • •Participant has provided written and dated informed consent to participate in the study
  • •Participant is willing and able to comply with the protocol
  • •Participant agrees to abstain from using caffeine, tobacco, and alcohol for at least 24 hours before testing days
  • •Participant agrees to abstain from exercise 24 hours prior to each testing visit
  • •Participant is not currently pregnant and does not desire to become pregnant in the next six months

排除标准

  • •Physicians on the research team believe that a pre-existing condition may influence participant safety or study outcomes, including previously diagnosed cardiovascular, metabolic, renal, hepatic, or musculoskeletal disorders
  • •Participant is using, or has used one of the following dietary supplements within 8 weeks prior to enrollment: creatine, β-hydroxy β-methylbutyrate, carnosine, beta-alanine, taurine, or any other supplement or prescription drug that may significantly influence body composition or metabolic rate
  • •Participant is in, or has participated in another clinical trial within 4 weeks prior to enrollment
  • •Participant is pregnant or plans on becoming pregnant
  • •Participant has a known allergy or sensitivity to any ingredient in the test product (determined from health history questionnaire)

研究组 & 干预措施

Protein Supplement

Experimental

Ready to drink blinded protein supplement

干预措施: Protein (Dietary Supplement)

Control

No Intervention

Control group

结局指标

主要结局

Number of patients reporting gastrointestinal effects during use of supplementation

时间窗: 12 weeks

Tracked using a custom survey

Number of shakes consumed out of the total number of shakes provided

时间窗: 12 weeks

次要结局

  • Body fat(12 weeks)
  • Lean body mass(12 weeks)
  • Metabolism (resting metabolic rate)(12 weeks)
  • Functional fitness (sit to stand test)(12 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验